Miami

The trials here

What the 3 trials at this site are about, from their registry records.

Conditions

• Alzheimer disease3 trials
• Schizophrenia1 trial

Phase

• Phase 33 trials

Status

• Active, not recruiting3 trials

Lead sponsor

• Karuna Therapeutics, Inc., a Bristol Myers Squibb company3 trials

Running trials

• Recruiting

  A Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)

  NCT06585787· Phase 3· Karuna Therapeutics, Inc., a Bristol Myers Squibb company· Source

• Recruiting

  A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-2)

  NCT06126224· Phase 3· Karuna Therapeutics, Inc., a Bristol Myers Squibb company· Source

• Recruiting

  A Study to Assess Efficacy and Safety of KarXT for the Treatment of Psychosis Associated With Alzheimer's Disease (ADEPT-1)

  NCT05511363· Phase 3· Karuna Therapeutics, Inc., a Bristol Myers Squibb company· Source